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Abstract
Background: Gene regulation in eukaryotes is a complex process entailing the establishment of transcriptionally
silent chromatin domains interspersed with regions of active transcription. Imprinted domains consist of clusters of
genes, some of which exhibit parent-of-origin dependent monoallelic expression, while others are biallelic. The
Kcnq1 imprinted domain illustrates the complexities of long-range regulation that coexists with local exceptions. A
paternally expressed repressive non-coding RNA, Kcnq1ot1, regulates a domain of up to 750 kb, encompassing 14
genes. We study how the Kcnq1 gene, initially silenced by Kcnq1ot1, undergoes tissue-specific escape from
imprinting during development. Specifically, we uncover the role of chromosome conformation during these
events.
Results: We show that Kcnq1 transitions from monoallelic to biallelic expression during mid gestation in the
developing heart. This transition is not associated with the loss of methylation on the Kcnq1 promoter. However,
by exploiting chromosome conformation capture (3C) technology, we find tissue-specific and stage-specific
chromatin loops between the Kcnq1 promoter and newly identified DNA regulatory elements. These regulatory
elements showed in vitro activity in a luciferase assay and in vivo activity in transgenic embryos.
Conclusions: By exploring the spatial organization of the Kcnq1 locus, our results reveal a novel mechanism by
which local activation of genes can override the regional silencing effects of non-coding RNAs.
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Background
Genomic imprinting is a transcriptional regulatory
mechanism that results in parental-specific gene expres-
sion. Over the past two decades, many mechanistic
insights have emerged from the study of such loci as the
H19/Igf2 domain [1]. However, most imprinted loci are
much more complex and exhibit tissue-specific as well
as stage-specific imprinting. Many significant questions
remain concerning the regulatory mechanisms govern-
ing such extended domains. For example, how genes
that are monoallelic can coexist interspersed with others
that exhibit partial or full biallelic expression is still not
understood. The prevalent hypotheses for the
appearance of imprinting imply that, although advanta-
geous in some respects, it imposed a burden on bystan-
der genes that came under its influence. Thus, it is
likely that mechanisms emerged to bypass the effects of
allelic silencing.
The Kcnq1 domain consists of at least ten genes exhi-
biting parental allele-specific expression [2], interspersed
with five genes that are biallelically expressed. The key
regulatory element, KvDMR, is a CG-rich promoter for
a long, non-coding RNA [3]. The paternal copy of the
KvDMR is hypomethylated and active, resulting in pro-
duction of a 90-kb non-coding RNA (ncRNA),
Kcnq1ot1.T r a n s c r i p t i o no ft h eKcnq1ot1 RNA has cis-
silencing effects on the neighboring genes, spanning a
region of 750 kb in the placenta and 400 kb in the
embryo. The KvDMR is methylated on the maternal
allele and as a consequence, maternal promoter activity
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most genes within the domain are free to be expressed
from that chromosome (Figure 1).
Recent experiments have strongly suggested that the
silencing mechanism of Kcnq1ot1 RNA involves a
spreading activity in cis, recruitment of Polycomb group
proteins and physical compaction of the whole domain
[4-6]. However, the presence of the ncRNA is not uni-
form throughout the region [4], leaving open the ques-
tion of how this relates to biallelic expression of some
genes.
Genes such as Trpm5 are constitutively biallelic both
in the embryo and placenta. The Kcnq1 gene has a
more complex pattern: it is monoallelic and ubiquitously
expressed in early embryos, but the paternal copy is
activated in conjunction with the acquisition of a tissue-
restricted expression pattern established by mid gesta-
t i o n ,t h a ti s ,i nt h eh e a r t ,k i d n e ya n db r a i n[ 7 ] .T h u s ,
the Kcnq1 domain illustrates the regulatory challenges
that must be met in a complex imprinted domain.
How do genes such as Kcnq1 achieve tissue-specific
escape from imprinting? One possible explanation is
that the Kcnq1 promoter is exceptionally strong and
that as tissue-specific factors become expressed and
bind to it, the silencing effect of Kcnq1ot1 is overcome.
Alternatively, tissue-specific enhancers that become
active may override the effects of ncRNAs. An addi-
tional possibility is that boundary elements serving as
barriers to the spread of the ncRNA may exist within
the Kcnq1 gene. These proposed mechanisms are not
mutually exclusive.
None of the regulatory elements that account for the
complex patterns of gene expression in this region have
been identified. We used an optimized approach for
identifying novel regulatory DNA elements and to deter-
mine their role in promoting escape from silencing. We
investigated the mechanism of Kcnq1 reactivation by
determining the in vivo spatial organization of the
Kcnq1 domain with chromosome conformation capture
(3C) assays [8,9]. We present evidence for the role of
specific DNA interactions by chromatin looping as a
mechanism for acquisition of tissue-specific expression.
These contacts occur during the developmental window
in which the paternal allele of Kcnq1 escapes silencing
by Kcnq1ot1. To determine if the regions contacted pre-
dominantly by the Kcnq1 promoter are regulatory ele-
ments, we integrated comparative genomics data and
publicly available genome-wide chromatin immunopre-
cipitation (ChIP) profiles and identified DNA sequences
that are candidates for modulating gene activity. Candi-
dates were tested in vitro and in vivo and several ele-
ments were identified as active transcriptional
enhancers. Their role in overriding RNA-mediated
repression is discussed.
Results
Kcnq1 RNA transitions from monoallelic to biallelic
expression during development
Congenital long QT syndrome type I is a cardiac disor-
der in which defects in KCNQ1, a voltage-gated potas-
sium channel, result in serious cardiac arrhythmias [10].
There is a wide range of phenotypes, with some indivi-
duals remaining mostly asymptomatic and others pre-
senting severe symptoms. Understanding the epigenetic
profile of Kcnq1 expression during cardiac development
will aid in understanding the molecular mechanisms
underlying the phenotypic variability. We determined
Kcnq1 expression levels during development to pinpoint
the exact timing of the switch from monoallelic to bial-
lelic expression (Figure 2A). Allele-specific reverse tran-
scription (RT)-PCR showed that Kcnq1 switched from a
monoallelic to biallelic pattern between E13.5 and E14.5.
Kcnq1
Kcnq1ot1
Cdkn1c Slc22a18 Phlda2
KvDMR
~800 kb
~400 kb
Figure 1 Schematic of the Kcnq1 imprinted domain on mouse chromosome 7. The imprinting pattern in the embryo is shown. Arrows
indicate direction of transcription. Arrows above the genes represent maternal transcription, arrows below the line are paternal transcription and
genes with two arrows have biallelic expression.
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Page 2 of 11Expression emanating from the paternal allele became
progressively stronger, reaching levels equal to the
maternal allele (Figure 2B). To determine whether the
activation of the paternal Kcnq1 allele was accompa-
nied by an increase in total Kcnq1 RNA abundance,
quantitative (q)PCR on total RNAs from these stages
was performed. Whereas the transition from monoalle-
lic to biallelic expression is expected to double RNA
abundance, the total cellular RNA levels increased
eightfold (Figure 2C), suggesting that other enhancing
mechanisms are involved in achieving the final RNA
levels.
One possible explanation for escape of silencing by
the paternal Kcnq1 allele is that expression is initiated
from an alternative start site. However, we did not
observe any alternative transcripts after the transition
from monoallelic to biallelic expression, thus excluding
this hypothesis (data not shown). We then speculated
that, because the transcriptional start site (TSS) at
exon 1 lies within a strong CpG island, it could be
paternally methylated in the early embryo and become
demethylated upon activation. To determine if the
CpG island was methylated during spermatogenesis or
early embryogenesis, we performed methylated DNA
immunoprecipitation (MeDIP) on sperm and embryos
a t7 . 5d a y sp o s tc o i t u m( d p c )( F i g u r e2 D ) .N oD N A
methylation was detected on the paternal allele, sug-
gesting that the promoter is protected from primary
(gametic) and secondary (post fertilization) methyla-
tion, even though it is silent at these stages. Further-
more, as opposed to the secondary methylation of the
upstream Cdkn1c gene orchestrated by Kcnq1ot1,t h e
silencing effect of the ncRNA on Kcnq1 is not
mediated by DNA methylation.
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Figure 2 (A) Developmental imprinting pattern of Kcnq1. Allele-specific expression of Kcnq1 as assayed by reverse transcription (RT)-PCR and
restriction digest with NlaIII on E10.5, 11.5, 12.5, 13.5, 14.5, 16.5 and neonatal heart (nnH) from F1 hybrid B6(CAST7) × C57BL/6J crosses.
Digestion products specific for B6(CAST7) (maternal) and C57BL/6J (paternal) alleles are indicated. Positive signs (+) denote addition of NlaIII to
the RT-PCR product. (B) Quantification of relative paternal-specific and maternal-specific expression during development. (C) Kcnq1 RNA
abundance during stages of development in which the imprinting pattern switches from monoallelic to biallelic, as assayed by real-time PCR. (D)
Methylated DNA immunoprecipitation (MeDIP) analysis of the Kcnq1 and Kcnq1ot1 promoter regions in sperm and 7.5 days post coitum (dpc)
embryos. 5meC lane = DNA precipitated by antibody against methylated cytosine; IgG = non-specific immunoprecipitation; Input = DNA before
immunoprecipitation; - = no antibody control. Specific bands for Kcnq1 and Kcnq1ot1 are indicated; NS = non-specific amplification product. The
Kcnq1ot1 promoter is methylated maternally in 7.5 dpc embryos and unmethylated in sperm, thus serving as a positive control for
immunoprecipitation of methylated DNA in E7.5 DNA and a negative control in sperm DNA.
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conformation
Three-dimensional conformation of chromatin plays a
crucial role in bringing widespread regulatory elements
into close proximity [11-13]. 3C technology detects
interactions between DNA regions by in vivo crosslink-
ing of chromatin and PCR with primers specific for
novel junctions created by ligation of sequences that
were in close proximity through specific interactions. To
determine if the Kcnq1 promoter associated with speci-
fic DNA sequences in the neonatal heart, we performed
an unbiased, systematic 3C scan extending 12.6 kb
upstream of the promoter, spanning the 320 kb Kcnq1
gene and 31.3 kb downstream of the last exon. Our
strategy was to anchor the 3C assays with an invariant
primer at the Kcnq1 promoter (Figure 3A, white arrow-
head) and variable primers located in restriction frag-
ments across the domain (Figure 3A, fragments tested
are numbered from 1 to 26). Strong and highly specific
interactions were detected between the Kcnq1 promoter
and fragment 4 (Figure 3B, orange line, peak at -8 kb
upstream of Kcnq1). Additionally, there were weaker but
specific contact with fragments 11 and 12 (Figure 3B,
orange line, peak in intron 1).
To see if this profile was tissue specific, we performed
3C in neonatal brain, a tissue in which Kcnq1 is highly
expressed and also biallelic. The interaction profile
observed in the brain was distinct from that of the
heart. The Kcnq1 promoter strongly associated instead
with fragment 2 (Figure 3B, blue line, peak at -12 kb)
and showed no contact with fragment 12 in the intron.
T h e s ed a t as h o wt h a tt h e r ea r ed i s t i n c tt h r e e - d i m e n -
sional conformations that regulate expression in each
tissue and identify the contact regions as putative tissue-
specific enhancers.
These results were verified by carrying out the reci-
procal analysis, that is, 3C assays were anchored with a
primer in fragment 12 of intron 1 (Figure 3C, white
arrowhead at +24 kb). In the neonatal heart, we found
increased association between this region and the Kcnq1
promoter, but also with fragment 4, at -8 kb upstream.
We did not observe these contact points in neonatal
brain (data not shown). In addition, reciprocal analyses
with anchors at fragment 4 in neonatal heart (Figure
4B) and at fragment 2 in neonatal brain (Figure 4C)
confirmed the interactions between these sequences
with the Kcnq1 promoter region, underscoring the pre-
sence of tissue-specific conformations.
Onset of loop formation between the Kcnq1 promoter
and putative enhancers correlates with the monoallelic to
biallelic switch
We next looked for dynamic changes in the status of the
chromatin fiber related to the escape from silencing of
Kcnq1 by testing the conformation in E11.5 hearts. At
this stage, the paternal Kcnq1 allele is still silent (Figure
5). None of the interactions evident in the neonatal
heart and brain between the Kcnq1 promoter and
upstream regions was apparent in the embryos. How-
ever, there was a significant physical association of the
promoter with a region in intron 1, though restricted to
fragment 11 (Figure 5B, yellow line). Thus, monoallelic
expression is not dependent on contacts between the
promoter and the putative upstream enhancers. How-
ever, onset of loop formation with those regions does
correlate with the monoallelic to biallelic switch.
Distinct developmental history of potential regulatory
elements at the Kcnq1 locus
To expand the epigenetic profile of Kcnq1 to earlier
developmental stages, we performed locus-wide 3C
assays on mouse ES cells (Figure 5B, blue line). None of
the heart-specific contacts between the Kcnq1 promoter
and regions upstream were detected, but the interaction
with fragment 11 in intron 1 was already present. Thus,
3C assays show an interaction between the Kcnq1 pro-
moter and a region in intron 1 that is already apparent
in early stages of embryogenesis and becomes progres-
sively stronger as development ensues. Additionally, the
Kcnq1 promoter associates with upstream elements con-
comitantly with the transition from monoallelic to bial-
lelic expression. These upstream elements partner with
the Kcnq1 promoter in a tissue-specific fashion.
Sequences identified by contact analysis have enhancer
activity in vitro and in vivo
A search of publicly available databases including the
VISTA enhancer browser [14] revealed an intragenic
element (mm183) with a heart-specific expression pat-
tern in 11.5 dpc transgenic mouse embryos. This ele-
ment lies in fragment 10, immediately upstream of the
sequence contacted by the promoter in intron 1. This
strongly supports its role in the development of heart-
specific transcription of Kcnq1. Examination of conser-
vation profiles for the Kcnq1 region from the dCODE
website (http://www.dcode.org) [15] revealed discrete
evolutionarily conserved regions (ECRs) (parameters
set to 70% identity with a minimum length of 100 bp)
that were contained on restriction fragments that had
been tested in the 3C substrates (Figure 3). By combin-
ing in silico analysis and published epigenomic profiles,
including chromatin status [16] and occupancy of p300
[17], we selected ECRs that were good candidates for
enhancers, focusing on the intergenic region upstream
of the Kcnq1 gene, numbering them according to the
3C fragments they overlapped (Figure 6A,B). None of
these ECRs were conserved in opossum, chicken, frog
or fish.
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Page 4 of 11To determine whether these sequences had enhancer
activity in vitro, we cloned the DNA fragments upstream
of a luciferase reporter gene and tested enhancer activity
by transient transfection into NIH-3T3 cells (Figure 6C).
ECR 4, contained in fragment 4 that showed frequent
colocalization with the Kcnq1 promoter in neonatal
heart, had the most pronounced enhancer effect in vitro.
ECR 2, which associated with the Kcnq1 promoter in
the neonatal brain, did not show significant transcrip-
tional activity in this assay, suggesting that fibroblasts
Trpm5
1
6 23
12 10 14
26
Cdkn1c Kcnq1
45 7
13 11 9
Kcnq1ot1
15 8 16 17 18
20
19
21 22 23 24 25
0
20
40
60
80
-1 4 -9.4 -8.2 -7 -6.2 -4.5 -2 1 .8 3.5 5.6 1 4 24 1 43 1 60 1 89 233 252 265 31 7 320 322 324 332 336 337 359
Position (kb)
R
e
l
a
t
i
v
e
 
A
s
s
o
c
i
a
t
i
o
n
 
F
r
e
q
u
e
n
c
y
wt Heart wt Brain
A
B
C
0
20
40
60
-1 4 -9.4 -8.2 -7 -6.2 -4.5 -2 1 .8 3.5 5.6 1 4 1 43 1 60 1 89 233 252 265 31 7 320 322 324 332 336 337 359
Postion (kb)
R
e
l
a
t
i
v
e
 
A
s
s
o
c
i
a
t
i
o
n
 
F
r
e
q
u
e
n
c
y
wt Heart
Figure 3 Chromosome conformation capture (3C) mapping of long-range chromatin interactions in the Kcnq1 region in neonatal
tissues. (A) Genomic organization of the Kcnq1 region scanned in this study, spanning 387 kb. Dark boxes in the Kcnq1 gene are exons. Arrows
show direction of transcription; maternal-specific and paternal-specific expression is indicated above and below the line. Reactivated Kcnq1
expression is depicted as a red arrow. Vertical bars indicate only the AflIII/NcoI restriction sites analyzed in this study, with the fragments assayed
by the variable primers for contact with the Kcnq1 promoter numbered. White arrowhead indicates the anchor primer at the Kcnq1 promoter.
Graphical representation is not to scale. (B,C) Relative crosslinking frequency of regions interacting with the Kcnq1 promoter, with association
values plotted on the y-axis. Distances in kb relative to the Kcnq1 promoter are plotted along the x-axis (not to scale). Each value is derived from
three independent samples and the standard error is indicated. Hatched vertical line represents the anchor position. High crosslinking
frequencies with the anchor fragment indicate close proximity. (B) 3C map of neonatal heart and brain. (C) Reciprocal 3C analysis of heart-
specific interactions in the Kcnq1 region by anchoring the PCR reactions at fragment 12 (intron 1).
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Page 5 of 11may not contain the factors required for brain-specific
activity.
We next cloned several candidate sequences into an
enhancer reporter vector and transgenic mouse embryos
were generated. Several independent embryos were
assessed for LacZ activity at 9.5 and 13.5 dpc.
Reproducible staining in hindbrain, forebrain and thor-
acic region was observed with ECR4 at 13.5 dpc (Figure
6D), but none at 9.5 dpc (data not shown), recapitulating
the developmental expression pattern of Kcnq1.E C R 2
directed expression to hindbrain and forebrain in the
13.5 dpc embryos.
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Figure 4 Reciprocal chromosome conformation capture (3C) scans anchoring at evolutionarily conserved regions. (A) Genomic
organization of the Kcnq1 region scanned in this study, spanning 387 kb. Dark boxes in the Kcnq1 gene are exons. Arrows show direction of
transcription; maternal-specific and paternal-specific expression is indicated above and below the line. Reactivated Kcnq1 expression is depicted
as a red arrow. Vertical bars indicate the AflIII/NcoI restriction sites analyzed in this study, with the fragments assayed with the variable primers
for contact with the tissue-specific evolutionarily conserved regions (ECRs) numbered. White arrowhead, anchor primer for neonatal heart; gray
arrowhead, anchor primer for neonatal brain. Graphical representation is not to scale. (B) Relative crosslinking frequency of regions interacting
with ECR 4. The peaks correspond to the Kcnq1 promoter and fragment 12 within intron 1. (C) Relative crosslinking frequency of regions
interacting with ECR 2. The peaks correspond to the Kcnq1 promoter and fragment 12 within intron 1. Hatched vertical lines represent the
anchor position.
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Our data reveal a novel role for transcriptional enhan-
cers, namely overcoming regional imprinting effects to
permit escape from silencing and leading to biallelic
expression. Thus, the evolution of enhancers in the
mammalian genome to enable biallelic expression of
some genes located near imprinted genes appears to be
an essential adaptation to accommodate imprinting as a
regulatory mechanism. By mapping the architecture
adopted by a specific genomic region during develop-
ment, we have found dynamic changes that counter the
regional repressive effect of a long non-coding RNA,
Kcnq1ot1. Specifically, escape from silencing of the
Kcnq1 gene is accomplished by the activation of tissue-
specific enhancers and involves local reorganization of
higher order structure.
The biallelic expression of genes within the Kcnq1
domain is reminiscent of certain genes on the × chro-
mosome that escape inactivation [18,19], but differs in
significant ways. Kcnq1 is initially silenced paternally but
transitions to biallelic expression at a specific time point
during development. In theory, tissue-specific enhancer
activity could override silencing by Kcnq1ot1 by physi-
cally contacting the promoter and sequestering it from
condensing factors recruited by the ncRNA. In fact, the
data from the 3C assays that we present are highly sup-
p o r t i v eo fs u c ham o d e lb ys h o w i n gt h a ts t a g ea n dt i s -
sue-specific conformations of chromatin bring the
Kcnq1 promoter into physical contact with DNA
sequences that are highly conserved and exhibit enhan-
cer activity in vivo.
In fact, we could distinguish two types of contacts. Pro-
moter interaction with an element in intron 1 (mm183)
is already apparent in early stages of embryogenesis and
becomes progressively stronger and broader as develop-
ment ensues. This association foreshadows a later event
in which the Kcnq1 promoter contacts tissue-specific
upstream elements concomitantly with the reactivation
of the paternal allele and the restriction of expression to
specific organs. Indeed, previous studies on the chroma-
tin marks in the region showed that, in contrast to other
neighboring genes, the Kcnq1 promoter does not exhibit
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Figure 5 Developmental profile of chromatin interactions in the Kcnq1 region. (A) Genomic organization of the Kcnq1 region scanned in
this study, spanning 387 kb. Dark boxes in the Kcnq1 gene are exons. Arrows show direction of transcription; maternal-specific and paternal-
specific expression is indicated above and below the line. Reactivated Kcnq1 expression is depicted as a red arrow. Vertical bars indicate only the
AflIII/NcoI restriction sites analyzed in this study, with the fragments assayed with the variable primers for contact with the Kcnq1 promoter
numbered. White arrowhead indicates the anchor primer at the Kcnq1 promoter. Graphical representation is not to scale. (B) Developmental
profile of interactions of the Kcnq1 promoter in ES cells, 11.5 days post coitum (dpc) heart, and neonatal heart. Relative crosslinking frequency of
regions interacting with the Kcnq1 promoter, with association values plotted on the y-axis. Distances in kb relative to the Kcnq1 promoter are
plotted along the x-axis (not to scale). Each value is derived from three independent samples and the standard error is indicated. Hatched
vertical line represents the anchor position. High crosslinking frequencies with the anchor fragment indicate close proximity.
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Figure 6 Identification and functional validation of candidate regulatory elements. (A) Representation of the upstream region of Kcnq1,
indicating the fragments tested in the chromosome conformation capture (3C) assays. (B) Graphic display of the conservation profiles for the
upstream region of Kcnq1. The base genome is mouse. Evolutionarily conserved regions (ECRs) of a minimum of 100 bp conserved above 70%
sequence identity are displayed as red (intergenic) peaks, with the x-axis representing positions in the base genome and the y-axis representing
percentage identity between the base and the aligned genomes. Annotated genes are depicted in blue. Numbered peaks represent the
fragments tested for enhancer activity. (C) DNA sequences were inserted in pGL3-promoter vector upstream of the luciferase reporter. Luciferase
activity was normalized to Renilla activity. All transfections were performed in triplicate. The asterisk denotes the interaction observed in neonatal
heart by 3C. (D) Representative LacZ-stained embryos with in vivo enhancer activity. ECR4 and ECR2 exhibit tissue-specific activity, with numbers
showing the reproducibility of LacZ reporter staining.
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Page 8 of 11differential histone modifications associated with repres-
sion [20,21], and our data indicate that it is also devoid of
DNA methylation on the paternal allele. We speculate
that the intragenic enhancer may be marked in early
embryogenesis by pioneer factors that maintain an open,
poised chromatin status [22] and prevent assembly of
repressive factors associated with the spreading of
Kcnq1ot1 [4,5].
We propose that as development proceeds, both the
upstream and downstream contacts evident in the 3C
assays promote a conformation that excludes the Kcnq1
promoter from the influence of the Kcnq1ot1 ncRNA by
establishing an autonomous regulatory loop (Figure 7A).
An alternative is that tissue-specific enhancer-driven
expression can override the silencing biochemically, by
countering the chromatin condensation directed by
Kcnq1ot1 (Figure 7B). In both cases, the DNA elements
involved are altering chromatin conditions locally,
thereby limiting a global long-range silencing mechan-
ism; in other words, they are establishing a boundary. It
will be crucial now to determine the DNA-binding fac-
tors that mediate this activity and the effect that deleting
these regions has on the expression and imprinting pat-
terns of Kcnq1 and neighboring genes. It will also be
important to test if mutations that eliminate Kcnq1ot1
expression can affect the remodeling of the Kcnq1 locus
during development. Additionally, it will be interesting
to see whether genes silenced by different epigenetic
mechanisms, either during development or in disease
states, are governed by similar conformational
determinants.
Conclusions
In summary, we have explored the organization of the
Kcnq1 region in three-dimensional nuclear space during
development and have identified DNA sequence ele-
ments that achieve the dual purpose of reactivating a
gene silenced by a non-coding RNA and directing tis-
sue-specific expression. Our studies underscore the
importance of providing a three-dimensional context to
the information on DNA methylation and chromatin
modifications in order to ful l yg r a s pt h ed y n a m i c so f
gene regulation in different cell lineages during
development.
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Figure 7 Model for escape from silencing by the Kcnq1 gene. Enhancer candidates, depicted as purple circles, become active upon binding
tissue-specific transcription factors (TF); ncRNA, wavy lines. (A) Appearance of enhancer-specific transcription factors promotes a conformational
change that sequesters the Kcnq1 promoter from the effects of Kcnq1ot1. (B) Factors binding in intron 1 of Kcnq1 act as a boundary for the
Kcnq1ot1 ncRNA on the paternal allele, leaving it available for tissue-specific activation by enhancer-binding regulatory proteins.
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Ethics
This study was carried out on mice in strict accordance
with the recommendations in the Guide for the Care
and Use of Laboratory Animals of the National Insti-
tutes of Health. The protocol was approved by the Tem-
ple University Animal Care and Use Committee
(Protocol 3294).
RNA purification
Heart tissues for total RNA extraction were collected at
appropriate days of gestation using F1 hybrid mice from
C57BL/6J × B6(CAST7) crosses from embryonic to neo-
natal stages. RNA was extracted using TRIzol Reagent
(Invitrogen, Carlsbad, CA no. 15596-018) and following
manufacturer’s protocol for RNA extraction from tis-
sues. All RNA samples were subjected to DNase treat-
ment using Turbo DNA-free (Ambion, Austin, TX no.
AM1907) using the rigorous DNase treatment protocol.
Three to five biological samples were collected for each
days of gestation.
Reverse transcription
Following the manufacturer’s instructions, complementary
DNA synthesis was performed on total RNA using Super-
Script II Reverse Transcriptase (Invitrogen, Carlsbad CA,
no. 18064-014). A reverse transcriptase negative control
was used to ensure there was no DNA contamination.
Real-time qRT-PCR
Transcript levels of Kcnq1 and b-actin were analyzed on
the ABI Prism 7000 system (ABI, Foster City, CA).
Reactions were conducted using the SYBR Green PCR
Master Mix (ABI, Foster City, CA no. 4309155). On a
96-well plate, a reduced reaction of 20 μl was used
instead of the suggested 50 μl indicated in the manufac-
turer’s protocol. This included 10 μl of the SYBR Green
reaction mix, a final concentration of 25 μM of each pri-
mer, the cDNA template and water to bring the final
volume up to 20 μl. The PCR was performed under the
following conditions: an initial denaturing step for 10
min at 95°C, an amplification step for 45 cycles of 95°C
for 20 s, 55°C for 30 s and 72°C for 30 s, the final elon-
gation step was at 72°C for 2 min. The Kcnq1 transcript
was detected using the following left and right primers:
5’-CAAAGACCGTGGCAGTAAC-3’ and 5’-CCTTCAT
TGCTGGCTACAAC-3’.T h eKcnq1 transcript was nor-
malized to b-actin using the following left and right pri-
mers: 5’-TGTTACCAACTGGGACGACA-3’ and 5’-
CCATCACAATGCCTGTGGTA-3’.E a c hq R T - P C R
reaction was performed in triplicate with three biological
replicates along with a no template negative control.
The CT value of the Kcnq1 transcript was normalized to
the CT value of the b-actin transcript. The standard
deviation for each ratio was determined and the error
bars represent 1 SD away from the average ratio.
Allele-specific RT-PCR and quantification
The Kcnq1 transcript was amplified using Ruby Taq
Master Mix (Affymetrix, Santa Clara, CA no. 71191) in
a reduced 15 μl reaction using the following primers: 5’-
CATCGGTGCCCGTCTGAACAGG-3’ and 5’-
TTGCTGGGTAGGAAGAGCTCAG-3’. PCR reactions
were performed with experimental and control tem-
plates in parallel. Following the PCR, a restriction digest
was performed with the NlaIII (New England Biolabs,
Ipswich, MA no. R0125) for 1 h at 37°C. PCR and diges-
tion products were run on 7% polyacrylamide gels and
quantified using the Kodak Gel Logic 2000 imaging sys-
tem (Kodak, Rochester, NY). The relative paternal to
maternal band intensities were calculated.
3C assays
3C was performed as described previously with the fol-
lowing modifications: tissues were homogenized and
crosslinked with 1% formaldehyde. Before restriction
enzyme digestion, all samples were subjected to RNAse
treatment with a combination of RNAse A and RNAse
H at 37°C for 20 minutes. Restriction digests were car-
ried out with AflIII/NcoI. Digestion efficiency at each
restriction site was determined by comparing amplifica-
tion with primers spanning the restriction site to ampli-
fication with primers immediately downstream on the
digested template. No restriction bias was observed
across the region assayed by 3C (data not shown). PCR
efficiency of each combination of primers was assessed
with a control template prepared from two bacterial
artificial chromosomes (BACs) encompassing the
Kcnq1ot1 region analyzed, as described previously. The
linear range for each primer pair was determined by
serial dilution. PCR reactions were performed with
experimental and control templates in parallel and PCR
products were run on 7% polyacrylamide gels and quan-
tified using the Kodak Gel Logic 2000 imaging system
(Kodak, Rochester, NY). Crosslinking frequencies were
calculated from duplicate PCR analyses of three inde-
pendent 3C preparations. Interaction frequencies for
Kcnq1 and Kcnq1ot1 were normalized to a control inter-
action at the H19 locus to allow comparisons between
different tissues and cell types. A full list of primers is
available upon request from the authors.
Luciferase reporter assays
Enhancer candidates were amplified from mouse geno-
mic DNA and subcloned into the pGL3-promoter vector
(Promega, Madison, WI) upstream of the luciferase
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structs were screened by transfection of 100 ng pGL3
promoter vector and 10 ng pHRL basic vector/well (24-
well plate) into NIH 3T3 cells with 1 μl Lipofectamine
2000/well (Invitrogen, Carlsbad, CA). Cell lysate was
harvested the following day and firefly and Renilla luci-
ferase activities were measured in 10 μl of each lysate
using a Dual-Luciferase Reporter Assay System kit (Pro-
mega, Madison, WI) and firefly activity was normalized
to Renilla. All transfections were performed in triplicate.
Transgenic embryo assays
Enhancer candidate constructs were amplified from
mouse genomic DNA, subcloned into the Hsp68-LacZ
vector and transgenic mouse embryos were generated
and stained (Cyagen Biosciences, Sunvale, CA). Images
were obtained with an Olympus MVX10 stereoscope
(Olympus, Center Valley, PA), cropped and levels
adjusted with Adobe Photoshop (Adobe, San Jose, CA).
Methyl-DNA immunoprecipitation
DNA from pooled mouse 7.5 dpc embryos and from
mouse sperm was sonicated to obtain fragments ranging
from 200 to 1,000 bp. An aliquot of DNA was saved for
an input positive control. Me-DIP was performed using
the Methylamp Methylated DNA Capture Kit (Epigen-
tek, Farmingdale, NY)) and following the manufacturer’s
protocol. The Kcnq1 CpG Island was amplified using
the following: 5’-CTGAGGGCAGCACGGTCTAT-3’
and 5’-CTCCTGAGTCTCTCTTGTCACAACT-3’. H19
and Kcnq1ot1 promoters were used to control the qual-
ity of the immunoprecipitated substrates.
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